These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8587855)

  • 1. Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal.
    Riesenman C
    Pharmacotherapy; 1995; 15(6 Pt 2):84S-99S. PubMed ID: 8587855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE; Ahern D; Scatina J; Kao J
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the risk of drug-drug interactions: a goal of rational drug development.
    Preskorn SH
    J Clin Psychiatry; 1996; 57 Suppl 1():3-6. PubMed ID: 8617709
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system.
    Ereshefsky L; Riesenman C; Lam YW
    J Clin Psychiatry; 1996; 57 Suppl 8():17-24; discussion 25. PubMed ID: 8698676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
    Ereshefsky L; Riesenman C; Lam YW
    Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antidepressants on the cytochrome P450 system.
    Preskorn SH
    Am J Psychiatry; 1996 Dec; 153(12):1655-7. PubMed ID: 8942473
    [No Abstract]   [Full Text] [Related]  

  • 7. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K
    Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interactions.
    Preskorn SH
    J Clin Psychiatry; 1996 May; 57(5):223-7. PubMed ID: 8626354
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin intoxication induced by fluvoxamine.
    Mamiya K; Kojima K; Yukawa E; Higuchi S; Ieiri I; Ninomiya H; Tashiro N
    Ther Drug Monit; 2001 Feb; 23(1):75-7. PubMed ID: 11206048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    Crewe HK; Lennard MS; Tucker GT; Woods FR; Haddock RE
    Br J Clin Pharmacol; 1992 Sep; 34(3):262-5. PubMed ID: 1389951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
    Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sertraline on protein binding of warfarin.
    Apseloff G; Wilner KD; Gerber N; Tremaine LM
    Clin Pharmacokinet; 1997; 32 Suppl 1():37-42. PubMed ID: 9068934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic interactions of antidepressants.
    Richelson E
    J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
    Ozdemir V; Naranjo CA; Shulman RW; Herrmann N; Sellers EM; Reed K; Kalow W
    J Clin Psychopharmacol; 1998 Jun; 18(3):198-207. PubMed ID: 9617978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
    Gregor KJ; Way K; Young CH; James SP
    J Affect Disord; 1997 Oct; 46(1):59-67. PubMed ID: 9387087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 isozymes and antiepileptic drug interactions.
    Levy RH
    Epilepsia; 1995; 36 Suppl 5():S8-13. PubMed ID: 8806399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of interleukin-10 on human cytochrome P450 activity.
    Gorski JC; Hall SD; Becker P; Affrime MB; Cutler DL; Haehner-Daniels B
    Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.